Literature DB >> 14697906

Amine oxidases and tumors.

P Pietrangeli1, B Mondovì.   

Abstract

The physiological function in living organisms of amine oxidases, is not completely established but is certainly related to the biogenic amines metabolism and therefore involved in essential processes such as the cell growth and differentiation. A correlation between degree of tumor malignancy and level of AO activity has been reported. The catalytic products of oxidative deamination of amines (hydrogen peroxide and aminoaldehyde) exert a cytotoxic effect and are considered cell growth inhibitors. The biogenic amines in same way could be considered in the cells as both poisons and protectors. A balance of oxidant and antioxidant enzymes appears to be very important in carcinogenesis and cell growth regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697906     DOI: 10.1016/S0161-813X(03)00109-8

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  8 in total

1.  Phosphonium compounds as new and specific inhibitors of bovine serum amine oxidase.

Authors:  Maria Luisa Di Paolo; Michele Lunelli; Marina Scarpa; Adelio Rigo
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

2.  Targeting monoamine oxidase A in advanced prostate cancer.

Authors:  Vincent Flamand; Hongjuan Zhao; Donna M Peehl
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-04       Impact factor: 4.553

3.  A molecular correlate to the Gleason grading system for prostate adenocarcinoma.

Authors:  Lawrence True; Ilsa Coleman; Sarah Hawley; Ching-Ying Huang; David Gifford; Roger Coleman; Tomasz M Beer; Edward Gelmann; Milton Datta; Elahe Mostaghel; Beatrice Knudsen; Paul Lange; Robert Vessella; Daniel Lin; Leroy Hood; Peter S Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-07       Impact factor: 11.205

4.  Inner-sphere mechanism for molecular oxygen reduction catalyzed by copper amine oxidases.

Authors:  Arnab Mukherjee; Valeriy V Smirnov; Michael P Lanci; Doreen E Brown; Eric M Shepard; David M Dooley; Justine P Roth
Journal:  J Am Chem Soc       Date:  2008-06-27       Impact factor: 15.419

5.  Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth.

Authors:  Gianfranco Alpini; Pietro Invernizzi; Eugenio Gaudio; Julie Venter; Shelley Kopriva; Francesca Bernuzzi; Paolo Onori; Antonio Franchitto; Monique Coufal; Gabriel Frampton; Domenico Alvaro; Sum P Lee; Marco Marzioni; Antonio Benedetti; Sharon DeMorrow
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

6.  Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.

Authors:  S Xu; H Adisetiyo; S Tamura; F Grande; A Garofalo; P Roy-Burman; N Neamati
Journal:  Br J Cancer       Date:  2015-06-23       Impact factor: 7.640

7.  Comparison of expression pattern of monoamine oxidase A with histopathologic subtypes and tumour grade of renal cell carcinoma.

Authors:  Ingrid Hodorová; Silvia Rybárová; Janka Vecanová; Peter Solár; Iveta Domorákova; Marián Adamkov; Jozef Mihalik
Journal:  Med Sci Monit       Date:  2012-12

8.  Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven events.

Authors:  Li Huang; Gabriel Frampton; Arundhati Rao; Kun-song Zhang; Wei Chen; Jia-ming Lai; Xiao-yu Yin; Kimberly Walker; Brianne Culbreath; Dinorah Leyva-Illades; Matthew Quinn; Matthew McMillin; Michelle Bradley; Li-Jian Liang; Sharon DeMorrow
Journal:  Lab Invest       Date:  2012-08-20       Impact factor: 5.662

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.